PLCG2 and small cell lung carcinoma: Moreover, the profibrotic and immunosuppressive monocyte/macrophage population (CD14+CD16+CD81+) was identified in SCLC (small cell lung cancer) tumors, related to PLCG2-high SCLC phenotype with stem-like and pro-metastatic features (58).